253 related articles for article (PubMed ID: 16681572)
1. UVA1 phototherapy for genital lichen sclerosus.
Beattie PE; Dawe RS; Ferguson J; Ibbotson SH
Clin Exp Dermatol; 2006 May; 31(3):343-7. PubMed ID: 16681572
[TBL] [Abstract][Full Text] [Related]
2. [Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosus et atrophicus].
Kreuter A; von Kobyletzki G; Happe M; Herde M; Breuckmann F; Stücker M; Altmeyer P
Hautarzt; 2001 Oct; 52(10):878-81. PubMed ID: 17690817
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
4. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
5. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
7. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement.
Kim GW; Park HJ; Kim HS; Kim SH; Ko HC; Kim BS; Kim MB
J Dermatol; 2012 Feb; 39(2):145-50. PubMed ID: 22044240
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases.
Rombold S; Lobisch K; Katzer K; Grazziotin TC; Ring J; Eberlein B
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):19-23. PubMed ID: 18201353
[TBL] [Abstract][Full Text] [Related]
9. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
Hengge UR; Krause W; Hofmann H; Stadler R; Gross G; Meurer M; Brinkmeier T; Frosch P; Moll I; Fritsch P; Müller K; Meykadeh N; Marini A; Ruzicka T; Gollnick H
Br J Dermatol; 2006 Nov; 155(5):1021-8. PubMed ID: 17034535
[TBL] [Abstract][Full Text] [Related]
10. UVA1 phototherapy for disseminated granuloma annulare.
Schnopp C; Tzaneva S; Mempel M; Schulmeister K; Abeck D; Tanew A
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):68-71. PubMed ID: 15752123
[TBL] [Abstract][Full Text] [Related]
11. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus.
Kreuter A; Jansen T; Stücker M; Herde M; Hoffmann K; Altmeyer P; Von Kobyletzki G
Clin Exp Dermatol; 2001 Jan; 26(1):30-2. PubMed ID: 11260173
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
13. High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea.
Lutz V; Francès C; Bessis D; Cosnes A; Kluger N; Godet J; Sauleau E; Lipsker D
Arch Dermatol; 2012 Jan; 148(1):24-8. PubMed ID: 22004877
[TBL] [Abstract][Full Text] [Related]
14. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study.
Kreuter A; Gambichler T; Avermaete A; Happe M; Bacharach-Buhles M; Hoffmann K; Jansen T; Altmeyer P; von Kobyletzki G
J Am Acad Dermatol; 2002 Feb; 46(2):251-5. PubMed ID: 11807437
[TBL] [Abstract][Full Text] [Related]
15. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
16. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.
Gambichler T; Terras S; Kreuter A
Clin Dermatol; 2013; 31(4):438-454. PubMed ID: 23806161
[TBL] [Abstract][Full Text] [Related]
17. [Penile lichen sclerosus: follow-up study].
Bouyssou-Gauthier ML; Boulinguez S; Dumas JP; Bedane C; Bonnetblanc JM
Ann Dermatol Venereol; 1999 Nov; 126(11):804-7. PubMed ID: 10612857
[TBL] [Abstract][Full Text] [Related]
18. Oral calcitriol: a new therapeutic agent in cutaneous lichen sclerosis.
Ronger S; Viallard AM; Meunier-Mure F; Chouvet B; Balme B; Thomas L
J Drugs Dermatol; 2003 Jan; 2(1):23-8. PubMed ID: 12852377
[TBL] [Abstract][Full Text] [Related]
19. Treatment of lichen sclerosus with carbon dioxide laser vaporization.
Kartamaa M; Reitamo S
Br J Dermatol; 1997 Mar; 136(3):356-9. PubMed ID: 9115915
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
